SE432589B - Peptidantibiotikum k 582 m-a och k 585 m-b och ett forfarande for framstellning derav genom odling av metarrhizium anisopliae (metsch) sorok, var anisopliae atcc 20500 - Google Patents

Peptidantibiotikum k 582 m-a och k 585 m-b och ett forfarande for framstellning derav genom odling av metarrhizium anisopliae (metsch) sorok, var anisopliae atcc 20500

Info

Publication number
SE432589B
SE432589B SE7813269A SE7813269A SE432589B SE 432589 B SE432589 B SE 432589B SE 7813269 A SE7813269 A SE 7813269A SE 7813269 A SE7813269 A SE 7813269A SE 432589 B SE432589 B SE 432589B
Authority
SE
Sweden
Prior art keywords
amino acid
ornithine
anisopliae
mixture
salt
Prior art date
Application number
SE7813269A
Other languages
English (en)
Swedish (sv)
Other versions
SE7813269L (sv
Inventor
S Kondo
Original Assignee
Kakenyaku Kako Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kakenyaku Kako Kk filed Critical Kakenyaku Kako Kk
Publication of SE7813269L publication Critical patent/SE7813269L/xx
Publication of SE432589B publication Critical patent/SE432589B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7813269A 1977-12-28 1978-12-22 Peptidantibiotikum k 582 m-a och k 585 m-b och ett forfarande for framstellning derav genom odling av metarrhizium anisopliae (metsch) sorok, var anisopliae atcc 20500 SE432589B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15741677A JPS5492914A (en) 1977-12-28 1977-12-28 Novel peptide antibiotic substance and its manufacture

Publications (2)

Publication Number Publication Date
SE7813269L SE7813269L (sv) 1979-06-29
SE432589B true SE432589B (sv) 1984-04-09

Family

ID=15649148

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7813269A SE432589B (sv) 1977-12-28 1978-12-22 Peptidantibiotikum k 582 m-a och k 585 m-b och ett forfarande for framstellning derav genom odling av metarrhizium anisopliae (metsch) sorok, var anisopliae atcc 20500

Country Status (13)

Country Link
US (1) US4221705A (nl)
JP (1) JPS5492914A (nl)
AU (1) AU518767B2 (nl)
CA (1) CA1115223A (nl)
DE (1) DE2856410C2 (nl)
ES (1) ES476430A1 (nl)
FR (1) FR2413094A1 (nl)
GB (1) GB2011425B (nl)
LU (1) LU80729A1 (nl)
NL (1) NL175294C (nl)
NZ (1) NZ189313A (nl)
SE (1) SE432589B (nl)
SU (1) SU786915A3 (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
JP5030777B2 (ja) * 2005-06-27 2012-09-19 日本化薬株式会社 生理活性物質nk13650p3、その製造法及び用途

Also Published As

Publication number Publication date
CA1115223A (en) 1981-12-29
ES476430A1 (es) 1979-11-16
FR2413094B1 (nl) 1982-09-03
SE7813269L (sv) 1979-06-29
AU518767B2 (en) 1981-10-22
NL175294B (nl) 1984-05-16
NL7812616A (nl) 1979-07-02
SU786915A3 (ru) 1980-12-07
FR2413094A1 (fr) 1979-07-27
LU80729A1 (fr) 1980-01-22
JPS5744664B2 (nl) 1982-09-22
GB2011425B (en) 1982-06-09
JPS5492914A (en) 1979-07-23
DE2856410A1 (de) 1979-07-05
NL175294C (nl) 1984-10-16
US4221705A (en) 1980-09-09
DE2856410C2 (de) 1983-01-05
GB2011425A (en) 1979-07-11
NZ189313A (en) 1981-10-19
AU4293978A (en) 1979-07-05

Similar Documents

Publication Publication Date Title
PT95876A (pt) Processo para a preparacao de novos polipeptidos
US4163780A (en) Ks-2-a
Gotoh et al. Studies on a new immunoactive peptide, FK-156 II. Fermentation, extraction and chemical and biological characterization
HU194317B (en) Process for production of a 40926 antibioticum-complex and its clean components, pa, pb,a,b and b under o factor and medical compounds containing thereof
DE3873845T2 (de) Antimikrobielles agens, fr 109 615 und seine herstellung.
US4247541A (en) Ks-2-b
US4268505A (en) Pharmaceutical composition comprising a nitrogen-containing polysaccharide and an antibiotic agent, and a method of treating an infectious disease therewith
EP0187722B1 (en) Antibiotics called "chloropolysporins b and c", a process for their preparation, and their therapeutic and veterinary use
SE432589B (sv) Peptidantibiotikum k 582 m-a och k 585 m-b och ett forfarande for framstellning derav genom odling av metarrhizium anisopliae (metsch) sorok, var anisopliae atcc 20500
US3639582A (en) Antibiotic laspartomycin
Synge Physical and chemical studies of gramicidin and some implications for the study of proteins
DE69518934T2 (de) Antibiotikum WAP-8294A, Verfahren zu seiner Herstellung und antibakterielle Zusammensetzung
DE69029315T2 (de) Verfahren zur Herstellung von Oxazopyrrolochinolinen, die sie enthaltenden Produkte und deren Verwendung
US4016260A (en) Novel polypeptide produced by pseudomonas
DE69217936T2 (de) Substanz wf11243
US3089816A (en) Lemacidine and process for its manufacture
DE3136675A1 (de) Neues peptid und dessen herstellung
US2771397A (en) Antibiotic and method for producing it by bacillus polymyxa
US2556376A (en) Recovery of polymyxin from fermentation broths
US3941762A (en) O-acyl derivatives of antibiotic EM-49
US3143468A (en) Capreomycin and its preparation
EP0084333B1 (en) Polysaccharide substance, process for the production of same, pharmaceutical compositions containing the same and their use as medicaments
US3061516A (en) Telomycin and its production
EP0640615A1 (de) Chelatoren, ihre Herstellung aus den Antibiotika Salmycin A, B, C oder D und deren Verwendung
US3316148A (en) Enomycin and process for preparation